433 related articles for article (PubMed ID: 31695789)
41. Hypoxia mediates mitochondrial biogenesis in hepatocellular carcinoma to promote tumor growth through HMGB1 and TLR9 interaction.
Tohme S; Yazdani HO; Liu Y; Loughran P; van der Windt DJ; Huang H; Simmons RL; Shiva S; Tai S; Tsung A
Hepatology; 2017 Jul; 66(1):182-197. PubMed ID: 28370295
[TBL] [Abstract][Full Text] [Related]
42. Coactivation of Foxa2 through Pgc-1beta promotes liver fatty acid oxidation and triglyceride/VLDL secretion.
Wolfrum C; Stoffel M
Cell Metab; 2006 Feb; 3(2):99-110. PubMed ID: 16459311
[TBL] [Abstract][Full Text] [Related]
43. MiR-205 modulates abnormal lipid metabolism of hepatoma cells via targeting acyl-CoA synthetase long-chain family member 1 (ACSL1) mRNA.
Cui M; Wang Y; Sun B; Xiao Z; Ye L; Zhang X
Biochem Biophys Res Commun; 2014 Feb; 444(2):270-5. PubMed ID: 24462768
[TBL] [Abstract][Full Text] [Related]
44. Estrogen-related receptor alpha directs peroxisome proliferator-activated receptor alpha signaling in the transcriptional control of energy metabolism in cardiac and skeletal muscle.
Huss JM; Torra IP; Staels B; Giguère V; Kelly DP
Mol Cell Biol; 2004 Oct; 24(20):9079-91. PubMed ID: 15456881
[TBL] [Abstract][Full Text] [Related]
45. Metabolic regulation by the PGC-1α and PGC-1β coactivators in larval zebrafish (Danio rerio).
Northam C; LeMoine CMR
Comp Biochem Physiol A Mol Integr Physiol; 2019 Aug; 234():60-67. PubMed ID: 31004809
[TBL] [Abstract][Full Text] [Related]
46. Targeting ODC1 inhibits tumor growth through reduction of lipid metabolism in human hepatocellular carcinoma.
Choi Y; Oh ST; Won MA; Choi KM; Ko MJ; Seo D; Jeon TW; Baik IH; Ye SK; Park KU; Park IC; Jang BC; Seo JY; Lee YH
Biochem Biophys Res Commun; 2016 Sep; 478(4):1674-81. PubMed ID: 27592554
[TBL] [Abstract][Full Text] [Related]
47. Multifaceted regulation of hepatic lipid metabolism by YY1.
Pan G; Diamanti K; Cavalli M; Lara Gutiérrez A; Komorowski J; Wadelius C
Life Sci Alliance; 2021 Jul; 4(7):. PubMed ID: 34099540
[TBL] [Abstract][Full Text] [Related]
48. Twist1-YY1-p300 complex promotes the malignant progression of HCC through activation of miR-9 by forming phase-separated condensates at super-enhancers and relieved by metformin.
Meng J; Han J; Wang X; Wu T; Zhang H; An H; Qin L; Sun Y; Zhong W; Yang C; Liu H; Sun T
Pharmacol Res; 2023 Feb; 188():106661. PubMed ID: 36669583
[TBL] [Abstract][Full Text] [Related]
49. Overexpression of NAD(P)H: Quinone Oxidoreductase 1 Inhibits Hepatocellular Carcinoma Cell Proliferation and Induced Apoptosis by Activating AMPK/PGC-1α Pathway.
Zhang X; Han K; Yuan DH; Meng CY
DNA Cell Biol; 2017 Apr; 36(4):256-263. PubMed ID: 28191864
[TBL] [Abstract][Full Text] [Related]
50. Cholesterol biosynthesis supports the growth of hepatocarcinoma lesions depleted of fatty acid synthase in mice and humans.
Che L; Chi W; Qiao Y; Zhang J; Song X; Liu Y; Li L; Jia J; Pilo MG; Wang J; Cigliano A; Ma Z; Kuang W; Tang Z; Zhang Z; Shui G; Ribback S; Dombrowski F; Evert M; Pascale RM; Cossu C; Pes GM; Osborne TF; Calvisi DF; Chen X; Chen L
Gut; 2020 Jan; 69(1):177-186. PubMed ID: 30954949
[TBL] [Abstract][Full Text] [Related]
51. Long noncoding RNA CPS1-IT1 suppresses the metastasis of hepatocellular carcinoma by regulating HIF-1α activity and inhibiting epithelial-mesenchymal transition.
Wang TH; Yu CC; Lin YS; Chen TC; Yeh CT; Liang KH; Shieh TM; Chen CY; Hsueh C
Oncotarget; 2016 Jul; 7(28):43588-43603. PubMed ID: 27248828
[TBL] [Abstract][Full Text] [Related]
52. Excess lipid availability increases mitochondrial fatty acid oxidative capacity in muscle: evidence against a role for reduced fatty acid oxidation in lipid-induced insulin resistance in rodents.
Turner N; Bruce CR; Beale SM; Hoehn KL; So T; Rolph MS; Cooney GJ
Diabetes; 2007 Aug; 56(8):2085-92. PubMed ID: 17519422
[TBL] [Abstract][Full Text] [Related]
53. Overexpression of PGC-1α increases peroxisomal activity and mitochondrial fatty acid oxidation in human primary myotubes.
Huang TY; Zheng D; Houmard JA; Brault JJ; Hickner RC; Cortright RN
Am J Physiol Endocrinol Metab; 2017 Apr; 312(4):E253-E263. PubMed ID: 28073778
[TBL] [Abstract][Full Text] [Related]
54. PGC-1alpha and PGC-1beta have both similar and distinct effects on myofiber switching toward an oxidative phenotype.
Mortensen OH; Frandsen L; Schjerling P; Nishimura E; Grunnet N
Am J Physiol Endocrinol Metab; 2006 Oct; 291(4):E807-16. PubMed ID: 16720625
[TBL] [Abstract][Full Text] [Related]
55. Diagnostic and prognostic relevance of CP2c and YY1 expression in hepatocellular carcinoma.
Kim JS; Son SH; Kim MY; Choi D; Jang IS; Paik SS; Chae JH; Uversky VN; Kim CG
Oncotarget; 2017 Apr; 8(15):24389-24400. PubMed ID: 28412749
[TBL] [Abstract][Full Text] [Related]
56. ACSL4 reprograms fatty acid metabolism in hepatocellular carcinoma via c-Myc/SREBP1 pathway.
Chen J; Ding C; Chen Y; Hu W; Yu C; Peng C; Feng X; Cheng Q; Wu W; Lu Y; Xie H; Zhou L; Wu J; Zheng S
Cancer Lett; 2021 Apr; 502():154-165. PubMed ID: 33340617
[TBL] [Abstract][Full Text] [Related]
57. Impairment of Fatty Acid Oxidation in Alveolar Epithelial Cells Mediates Acute Lung Injury.
Cui H; Xie N; Banerjee S; Ge J; Guo S; Liu G
Am J Respir Cell Mol Biol; 2019 Feb; 60(2):167-178. PubMed ID: 30183330
[TBL] [Abstract][Full Text] [Related]
58. The developmental regulation of peroxisome proliferator-activated receptor-gamma coactivator-1alpha expression in the liver is partially dissociated from the control of gluconeogenesis and lipid catabolism.
Yubero P; Hondares E; Carmona MC; Rossell M; Gonzalez FJ; Iglesias R; Giralt M; Villarroya F
Endocrinology; 2004 Sep; 145(9):4268-77. PubMed ID: 15178647
[TBL] [Abstract][Full Text] [Related]
59. Long-chain acyl-CoA synthetase 6 regulates lipid synthesis and mitochondrial oxidative capacity in human and rat skeletal muscle.
Teodoro BG; Sampaio IH; Bomfim LH; Queiroz AL; Silveira LR; Souza AO; Fernandes AM; Eberlin MN; Huang TY; Zheng D; Neufer PD; Cortright RN; Alberici LC
J Physiol; 2017 Feb; 595(3):677-693. PubMed ID: 27647415
[TBL] [Abstract][Full Text] [Related]
60. Disorder of fatty acid metabolism in the kidney of PAN-induced nephrotic rats.
Muroya Y; Ito O; Rong R; Takashima K; Ito D; Cao P; Nakamura Y; Joh K; Kohzuki M
Am J Physiol Renal Physiol; 2012 Oct; 303(7):F1070-9. PubMed ID: 22874759
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
